Do CYP2C19 polymorphisms affect the antiplatelet effect of clopidogrel in Japanese patients?
CYP2C19 polymorphisms significantly impact the antiplatelet efficacy of clopidogrel in Japanese patients in real-world settings.
CYP2C19 polymorphisms are frequent in Japanese, and the antiplatelet effect of clopidogrel is strongly affected by them in the real-world clinical setting.
Jinnai et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: